Latest / The William Blair Thinking Podcast
GLP-1s: The $100 Billion Answer to a Trillion-Dollar Challenge
Ryan Daniels, CFA, partner and group head of healthcare technology and services, discusses the impact of GLP-1 drugs on healthcare spending and care delivery, along with the need for healthcare services and digital health providers that can help employers and consumers effectively manage the emerging wave of GLP-1 drugs.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.